Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

14,500

Employees14,500

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

14,500

Employees14,500

ZTS Key Statistics

Market cap

54.45B

Market cap54.45B

Price-Earnings ratio

21.77

Price-Earnings ratio21.77

Dividend yield

1.55%

Dividend yield1.55%

Average volume

4.28M

Average volume4.28M

High today

$131.10

High today$131.10

Low today

$127.09

Low today$127.09

Open price

$129.24

Open price$129.24

Volume

3.00M

Volume3.00M

52 Week high

$177.00

52 Week high$177.00

52 Week low

$115.25

52 Week low$115.25

Stock Snapshot

The current Zoetis(ZTS) stock price is $128.96, with a market capitalization of 54.45B. The stock trades at a price-to-earnings (P/E) ratio of 21.77 and offers a dividend yield of 1.5%.

As of 2026-03-02, Zoetis(ZTS) stock has fluctuated between $127.09 and $131.10. The current price stands at $128.96, placing the stock +1.5% above today's low and -1.6% off the high.

Zoetis(ZTS) shares are trading with a volume of 3M, against a daily average of 4.28M.

In the last year, Zoetis(ZTS) shares hit a 52-week high of $177.00 and a 52-week low of $115.25.

ZTS News

Nasdaq 13h

Neogen To Sell Genomics Business To Zoetis For $160 Mln

(RTTNews) - Neogen Corporation (NEOG), a food safety solutions provider, Monday announced that it has agreed to sell its genomics business to Zoetis Inc., an an...

TipRanks 13h

Zoetis to acquire Neogen animal genomics business for $160M

Zoetis (ZTS) announced it has entered into a definitive agreement with Neogen (NEOG) to acquire Neogen’s animal genomics business for $160M, subject to customar...

Simply Wall St 6d

Zoetis Valuation Check After Earnings Beat And 2026 Guidance Above Expectations

Zoetis (ZTS) is back in focus after reporting its fourth quarter and full year 2025 results, pairing higher sales and net income with 2026 guidance that managem...

Analyst ratings

62%

of 21 ratings

Buy

61.9%

Hold

38.1%

Sell

More ZTS News

Simply Wall St 7d

Zoetis’ Earnings and Buybacks Could Be A Game Changer For Zoetis - simplywall.st

...

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.